pSivida Corp (NASDAQ:PSDV)

Data as of 2:05pm ET
 +0.02 / +0.54%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

pSivida Corp. develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and BioSilico is focused on treatment of chronic diseases of the back of the eye. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. The company was founded by Roger Aston in March 2008 and is headquartered in Waterson, MA.

Contact Information

pSivida Corp.
400 Pleasant Street
Waterson Massachusetts 02472
P:(617) 926-5000
Investor Relations:
(141) 228-1780



Other institutional30.05%
Mutual fund holders3.70%
Individual stakeholders2.16%

Top Executives

Paul AshtonPresident, Chief Executive Officer & Director
Marty NazzaroVice President-Operations
Leonard S. RossChief Financial Officer & Vice President
Hong GuoVice President-Research
Lori H. FreedmanSecretary, VP-Corporate Affairs & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.